Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASAH1 | Q13510 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 2/20 | 0.43 |
| ▸ | CDC25A | P30304 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.42 |
| ▸ | FEN1 | P39748 | 1/20 | 0.42 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL1703872 | 0.86 | NR1H2 (0.47) | ASAH1NR1H2NR1H3ALDH1A1ALDH2 | |
| Hexanoate SCHEMBL28556025 | 0.80 | AKR1B1 (0.52) | ASAH1ALDH1A1CES1CA12CA9 | |
| SCHEMBL27719449 | 0.79 | ASAH1 (0.44) | ASAH1NR1H2NR1H3ALDH1A1ALDH2 | |
| Valeric Acid SCHEMBL27568555 | 0.78 | CA12 (0.47) | ASAH1ALDH1A1CES1CA12CA9 | |
| SCHEMBL710689 | 0.77 | ERCC1 (0.62) | ALDH1A1CA12CA9ERCC1FEN1 | |
| SCHEMBL29361703 | 0.77 | ERCC1 (0.62) | ALDH1A1CA12CA9ERCC1FEN1 | |
| SCHEMBL1410 | 0.77 | ERCC1 (0.62) | ALDH1A1CA12CA9ERCC1FEN1 | |
| Tetrabuthylammonium SCHEMBL8967565 | 0.75 | SLC22A1 (0.44) | NR1H2NR1H3ALDH1A1ALDH2ALDH3A1 | |
| Tetrabuthylammonium SCHEMBL8967570 | 0.75 | GSK3B (0.56) | ALDH1A1ALDH2ALDH3A1CES1CDC25A | |
| SCHEMBL2824834 | 0.74 | ERCC1 (0.60) | ALDH1A1CA12CA9ERCC1FEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2440557-B1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2017-04-05 | — | — | EP | disclosed |
| US-9045480-B2 | Sterically hindered amine light stabilizers | BASF SE (DE) | 2015-06-02 | — | — | US | disclosed |
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2012-05-03 | — | — | US | disclosed |
| EP-2440557-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010142576-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2010-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | AAAS, CRY1, TAAR1 | ASAH1 1653/4885NR1H2 1925/4885NR1H3 1869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.